Tag
GlaxoSmithKline Pharmaceuticals Limited
2 articles
GlaxoSmithKline Pharmaceuticals Schedules Analyst Meeting
GlaxoSmithKline Pharmaceuticals intimates scheduled analyst/investor meeting on 3rd August 2026 via digital platform.
Disclosure made under SEBI Listing Regulations Regulation 30 and Schedule III requ
GSK Pharma Board Meeting for Q1 FY27 Results
GSK Pharmaceuticals will hold a board meeting on August 3, 2026 to consider and approve unaudited Q1 FY2027 financial results.
The disclosure is a mandatory regulatory filing under SEBI LODR Regulatio